B Acute Lymphoblastic Leukemia, BCR-ABL1-Like

specific

A subtype of high risk B cell acute lymphoblastic leukemia (ALL) in which patients have a gene-expression profile similar to that of BCR-ABL1 positive ALL, but who all lack the BCR-ABL1 fusion gene. Similar to patients with BCR-ABL1 positive ALL, patients with Ph-like ALL frequently harbor alterations in lymphoid transcription factors. This is clinically important because of the presence of kinase-activating alterations that are amenable to treatment with currently available tyrosine kinase inhi

58

Centers

97

Active Trials

Cancer Funding

Top Centers for B Acute Lymphoblastic Leukemia, BCR-ABL1-Like(58)

Ranked by research excellence score (trials · grants · publications). Methodology →

#CenterScore
1
NCI Comprehensive
Active Research Program
58.2
2
NCI Comprehensive
Active Research Program
58.2
3
NCI Comprehensive
Active Research Program
58.2
4
NCI Comprehensive
Active Research Program
58.2
5
NCI Comprehensive
Active Research Program
58.2
6
NCI Comprehensive
Active Research Program
58.2
7
NCI Comprehensive
Active Research Program
58.2
8
NCI Comprehensive
Active Research Program
58.2
9
NCI Comprehensive
Active Research Program
58.2
10
NCI Comprehensive
Active Research Program
58.2
1158.2
12
NCI Comprehensive
Active Research Program
58.2
13
NCI Comprehensive
Active Research Program
58.2
14
NCI Comprehensive
Active Research Program
58.2
15
NCI Clinical
Active Research Program
58.2
16
NCI Comprehensive
Active Research Program
58.2
17
NCI Clinical
Active Research Program
58.2
18
NCI Comprehensive
Active Research Program
58.2
19
Active Research Program
58.2
20
NCI Comprehensive
Active Research Program
58.2
21
Active Research Program
58.2
22
NCI Comprehensive
Active Research Program
58.2
23
NCI Clinical
Active Research Program
58.2
24
NCI Comprehensive
Active Research Program
58.2
25
Rutgers Cancer InstituteNew Brunswick, NJ
NCI Comprehensive
Active Research Program
58.2
26
Active Research Program
58.2
27
NCI Clinical
Active Research Program
58.2
28
NCI Comprehensive
Active Research Program
58.2
29
Active Research Program
58.2
3058.2
31
Active Research Program
58.2
32
Active Research Program
58.2
33
Active Research Program
58.2
34
Active Research Program
58.2
35
Active Research Program
58.2
36
Active Research Program
58.2
37
Active Research Program
58.2
38
Active Research Program
58.2
39
Active Research Program
58.2
40
NCI Comprehensive
Active Research Program
35.7
41
NCI Comprehensive
Active Research Program
35.7
42
NCI Comprehensive
Active Research Program
35.7
43
Masonic Cancer CenterMinneapolis, MN
NCI Comprehensive
Active Research Program
35.7
44
NCI Comprehensive
Active Research Program
35.7
45
NCI Comprehensive
Active Research Program
35.7
46
Cedars-Sinai CancerLos Angeles, CA
Active Research Program
35.7
47
Active Research Program
35.7
48
NCI Comprehensive
Active Research Program
35.7
49
NCI Comprehensive
Active Research Program
35.7
50
Active Research Program
35.7
51
NCI Comprehensive
Active Research Program
35.7
52
Active Research Program
35.7
53
Active Research Program
35.7
5435.7
55
Active Research Program
35.7
56
Active Research Program
35.7
57
Active Research Program
35.7
58
BC CancerVancouver, BC
Active Research Program
35.7

Research tier badges reflect trial volume, NIH grant funding, and publication impact — not clinical outcomes or patient satisfaction. Learn about our methodology →